Aristide Merola

Best Publications

• Technology in Parkinson's disease: Challenges and opportunities.

  Alberto J. Espay;Paolo Bonato;Fatta B. Nahab;Walter Maetzler

  688
  Citations

• Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.

  Marco Vercellino;Silvia Masera;Marcella Lorenzatti;Cecilia Condello

  338
  Citations

• Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts.

  Alberto J. Espay;Francesca Morgante;Aristide Merola;Alfonso Fasano;Alfonso Fasano

  326
  Citations

• A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologies

  Alberto J. Espay;Jeffrey M. Hausdorff;Jeffrey M. Hausdorff;Jeffrey M. Hausdorff;Álvaro Sánchez‐Ferro;Jochen Klucken

  290
  Citations

• Altered Glutamate Reuptake in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis Cortex: Correlation With Microglia Infiltration, Demyelination, and Neuronal and Synaptic Damage

  Marco Vercellino;Aristide Merola;Chiara Piacentino;Barbara Votta

  264
  Citations

• Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.

  Alberto J. Espay;Joaquin A. Vizcarra;Luca Marsili;Anthony E. Lang

  251
  Citations

• Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease.

  Maurizio Zibetti;Aristide Merola;Laura Rizzi;Valeria Ricchi

  237
  Citations

• Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease?

  Mg Rizzone;Alfonso Fasano;Antonio Daniele;M Zibetti

  218
  Citations

• Deconstructing normal pressure hydrocephalus: Ventriculomegaly as early sign of neurodegeneration

  Alberto J. Espay;Gustavo A. Da Prat;Alok K. Dwivedi;Federico Rodriguez‐Porcel

  212
  Citations

• Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation : A neuropathological study

  Marco Vercellino;Barbara Votta;Cecilia Condello;Chiara Piacentino

  177
  Citations

• Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study.

  Roberto Ceravolo;Giovanni Cossu;Monica Bandettini di Poggio;Lucio Santoro

  176
  Citations

• Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials.

  Alberto J. Espay;Michael A. Schwarzschild;Caroline M. Tanner;Hubert H. Fernandez

  169
  Citations

• Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.

  Aristide Merola;Maurizio Zibetti;Serena Angrisano;Laura Rizzi

  168
  Citations

• Autonomic dysfunction in Parkinson's disease: A prospective cohort study

  Aristide Merola;Alberto Romagnolo;Michela Rosso;Ritika Suri

  155
  Citations

• Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets

  Alberto J Espay;Peter A LeWitt;Peter A LeWitt;Robert A Hauser;Aristide Merola

  154
  Citations

• Telemedicine in Neurological Disorders: Opportunities and Challenges

  Martina Chirra;Luca Marsili;Linsdey Wattley;Leonard L Sokol

  146
  Citations

• Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients: a 15 months follow-up study.

  Valeria Ricchi;Maurizio Zibetti;Serena Angrisano;Aristide Merola

  139
  Citations

• Adaptive deep brain stimulation controls levodopa-induced side effects in Parkinsonian patients

  Manuela Rosa;Mattia Arlotti;Mattia Arlotti;Sara Renata Francesca Marceglia;Sara Renata Francesca Marceglia;Filippo Cogiamanian

  129
  Citations

• Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience.

  M Zibetti;Aristide Merola;Ca Artusi;Laura Rizzi

  124
  Citations

• Essential pitfalls in "essential" tremor.

  Alberto J. Espay;Anthony E. Lang;Roberto Erro;Aristide Merola

  107
  Citations